GARY ALDRICH: Open Payments
NPI 1629474978 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,012 in 100 payments from 19 companies in 2025. Trend: 2023 $2,413 · 2024 $1,990 · 2025 $2,012
Food & beverage: $1,854Education: $158
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $427 |
| ABBVIE INC. | 14 | $278 |
| PFIZER INC. | 10 | $148 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $145 |
| GENZYME CORPORATION | 5 | $144 |
| Amgen Inc. | 5 | $129 |
| Regeneron Healthcare Solutions, Inc. | 4 | $122 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| Incyte Corporation | 4 | $102 |
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
Products named: TREMFYA, DUPIXENT, RINVOQ, CIBINQO, OTEZLA, ILUMYA, SKYRIZI, OPZELURA.
Industry payments across IA — which companies pay providers there.
